Anna Gidari

742 total citations
28 papers, 460 citations indexed

About

Anna Gidari is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Gidari has authored 28 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 7 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Gidari's work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (12 papers) and SARS-CoV-2 detection and testing (5 papers). Anna Gidari is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (12 papers) and SARS-CoV-2 detection and testing (5 papers). Anna Gidari collaborates with scholars based in Italy, United States and Iran. Anna Gidari's co-authors include Daniela Francisci, Samuele Sabbatini, Giuseppe Vittorio De Socio, Sabrina Bastianelli, Chiara Busti, Sara Pierucci, Claudia Monari, Elisabetta Schiaroli, Anna Maria Stabile and Desirée Bartolini and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Microbiology and Biochemical Pharmacology.

In The Last Decade

Anna Gidari

26 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Gidari Italy	13	284	90	89	60	48	28	460
Simone Meini Italy	15	226 0.8×	81 0.9×	89 1.0×	109 1.8×	135 2.8×	41	755
Maureen Mo-Lin Wong China	7	544 1.9×	73 0.8×	92 1.0×	135 2.3×	47 1.0×	10	650
Deba Prasad Dhibar India	13	298 1.0×	117 1.3×	60 0.7×	93 1.6×	124 2.6×	63	724
Arto Yuwono Soeroto Indonesia	11	387 1.4×	38 0.4×	115 1.3×	124 2.1×	49 1.0×	43	565
Erich Pawelka Austria	12	443 1.6×	36 0.4×	76 0.9×	159 2.6×	92 1.9×	28	590
Ashish Bhargava United States	13	248 0.9×	53 0.6×	204 2.3×	81 1.4×	57 1.2×	58	860
Voichița Elena Lăzureanu Romania	13	230 0.8×	55 0.6×	63 0.7×	123 2.0×	65 1.4×	56	483
Ertuğrul Güçlü Türkiye	15	237 0.8×	31 0.3×	159 1.8×	72 1.2×	125 2.6×	64	688
Zahra Sahraei Iran	6	159 0.6×	21 0.2×	72 0.8×	50 0.8×	78 1.6×	19	523
Vikram Thakur India	13	369 1.3×	24 0.3×	68 0.8×	82 1.4×	129 2.7×	27	656

Countries citing papers authored by Anna Gidari

Since Specialization

Citations

This map shows the geographic impact of Anna Gidari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gidari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gidari more than expected).

Fields of papers citing papers by Anna Gidari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gidari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gidari. The network helps show where Anna Gidari may publish in the future.

Co-authorship network of co-authors of Anna Gidari

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gidari. A scholar is included among the top collaborators of Anna Gidari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gidari. Anna Gidari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pallotto, Carlo, et al.. (2025). Colonisation at admission to an intensive care unit in an Italian University Hospital: Risk factors and clinical implications. Journal of Infection Prevention. 26(4). 153–160.

Pallotto, Carlo, Paolo Milani, Donatella Pietrella, et al.. (2024). Pseudomonas aeruginosa Isolation from Urine Culture in Hospitalised Patients: Incidence of Complicated Urinary Tract Infections and Asymptomatic Bacteriurias and Impact on Treatment of the EUCAST 2020 Update. Antibiotics. 13(12). 1206–1206. 1 indexed citations

Pariano, Marilena, Anna Gidari, Claudia Stincardini, et al.. (2024). Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis. Journal of Fungi. 10(7). 510–510. 2 indexed citations

Pallotto, Carlo, et al.. (2024). Bloodstream Infections Due to Wild-Type Pseudomonas aeruginosa: Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes. Infectious Disease Reports. 16(5). 828–835. 2 indexed citations

Gidari, Anna, Carlo Pallotto, & Daniela Francisci. (2024). Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series. Infection. 52(6). 2145–2168. 3 indexed citations

Gidari, Anna, Samuele Sabbatini, Sabrina Bastianelli, et al.. (2024). Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants?. Viruses. 16(3). 354–354. 3 indexed citations

Gidari, Anna, Samuele Sabbatini, Elisabetta Schiaroli, et al.. (2023). The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2251721–2251721. 8 indexed citations

Schiaroli, Elisabetta, Anna Gidari, Roberta Spaccapelo, et al.. (2023). Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients. Journal of Clinical Virology. 168. 105584–105584. 3 indexed citations

Socio, Giuseppe Vittorio De, et al.. (2023). Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV. Journal of Clinical Medicine. 12(24). 7759–7759. 5 indexed citations

10.

Paciaroni, Alessandro, Francesca Ripanti, A. Orecchini, et al.. (2023). Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir. International Journal of Molecular Sciences. 24(7). 6062–6062. 12 indexed citations

11.

Gidari, Anna, Samuele Sabbatini, Elisabetta Schiaroli, et al.. (2023). Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report. Viruses. 15(7). 1577–1577. 12 indexed citations

12.

Gidari, Anna, et al.. (2023). Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH). Infectious Disease Reports. 15(6). 766–777.

13.

Gidari, Anna, Samuele Sabbatini, Elisabetta Schiaroli, et al.. (2022). The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro. Microorganisms. 10(7). 1475–1475. 27 indexed citations

14.

Gidari, Anna, Samuele Sabbatini, Sabrina Bastianelli, et al.. (2021). SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light. Viruses. 13(3). 408–408. 86 indexed citations

15.

Bartolini, Desirée, Anna Maria Stabile, Sabrina Bastianelli, et al.. (2021). SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione. Redox Biology. 45. 102041–102041. 68 indexed citations

16.

Biagioli, Michele, Silvia Marchianò, Rosalinda Roselli, et al.. (2021). Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction. Biochemical Pharmacology. 188. 114564–114564. 21 indexed citations

17.

Gidari, Anna, Samuele Sabbatini, Sabrina Bastianelli, et al.. (2021). Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected. Journal of Infection. 83(4). 467–472. 22 indexed citations

18.

Mencacci, Antonella, Alessio Gili, Anna Gidari, et al.. (2021). Role of Nucleocapsid Protein Antigen Detection for Safe End of Isolation of SARS-CoV-2 Infected Patients with Long Persistence of Viral RNA in Respiratory Samples. Journal of Clinical Medicine. 10(18). 4037–4037. 6 indexed citations

19.

Gidari, Anna, Sabrina Bastianelli, Samuele Sabbatini, et al.. (2020). Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature. European Journal of Clinical Microbiology & Infectious Diseases. 40(1). 1–12. 32 indexed citations

20.

Gidari, Anna, Samuele Sabbatini, Elisabetta Schiaroli, et al.. (2020). Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm. Frontiers in Microbiology. 11. 2085–2085. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact